KIDNEY TRANSPLANT REJECTION
Clinical trials for KIDNEY TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kidney transplant patients: drug may reduce rejection and diabetes risk
Disease control CompletedThis study tested a new medicine called tegoprubart in 127 people receiving their first kidney transplant. The goal was to see if it works better than the standard drug tacrolimus at preventing organ rejection and reducing side effects like new-onset diabetes. Participants were r…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2 • Sponsor: Eledon Pharmaceuticals • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Common virus may hold key to safer kidney transplants
Knowledge-focused CompletedThis study looked at whether levels of a common, harmless virus (Torque Teno virus) in the blood can predict infections or organ rejection in kidney transplant recipients who are on stable anti-rejection medication. Researchers followed 172 patients for at least a year, measuring…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Sponsor: Singapore General Hospital • Aim: Knowledge-focused
Last updated May 01, 2026 15:59 UTC